NCT07118176 Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Status RECRUITING Phase PHASE1
NCT07090499 A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07043972 Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma Status RECRUITING Phase PHASE2
NCT07037589 Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? Status RECRUITING Phase N/A
NCT06999187 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas Status RECRUITING Phase PHASE1
NCT06994078 Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors Status NOT_YET_RECRUITING Phase NA
NCT06967961 Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers Status RECRUITING Phase NA
NCT06966024 Study of DCC-2812 in Participants With Advanced Genitourinary Cancers Status RECRUITING Phase PHASE1
NCT06943521 A Study of MT-4561 in Patients With Various Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06912672 Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma Status NOT_YET_RECRUITING Phase N/A
NCT06857175 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01) Status RECRUITING Phase PHASE3
NCT06823427 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma Status RECRUITING Phase PHASE2
NCT06774131 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer Status RECRUITING Phase PHASE3
NCT06695845 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors Status RECRUITING Phase PHASE2
NCT06682728 Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence Status RECRUITING Phase PHASE2
NCT06632951 Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06592326 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer Status RECRUITING Phase PHASE3